W
COLL icon

WealthCollab’s Collegium Pharmaceutical COLL Stock Holding History

WealthCollab’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.85K Hold
86
– – ﹤0.01% 798
2025
Q4 		$3.98K Hold
86
– – ﹤0.01% 776
2025
Q3 		$3.01K Hold
86
– – ﹤0.01% 771
2025
Q2 		$2.54K Sell
86
-347
-80% -$9.9K ﹤0.01% 784
2025
Q1 		$12.9K Sell
433
-98
-18% -$3K 0.01% 409
2024
Q4 		$15.2K Buy
531
+253
+91% +$8.37K 0.01% 372
2024
Q3 		$10.7K Buy
278
+71
+34% +$2.53K 0.01% 445
2024
Q2 		$6.67K Buy
+207
New +$7.18K ﹤0.01% 511

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

WealthCollab's COLL Position: Q1 2026 in Review

WealthCollab held its Collegium Pharmaceutical (COLL) position steady in Q1 2026 at 86 shares worth $2.85K. The position accounts for ﹤0.01% of the portfolio, ranked #798.

WealthCollab first reported a position in COLL in Q2 2024 and has held it in 8 quarters since. The position peaked at $15.2K in Q4 2024. 266 funds tracked by Wall St. Rank hold COLL as of Q1 2026.

  • WealthCollab held 86 shares of Collegium Pharmaceutical worth $2.85K as of Q1 2026.
  • WealthCollab left its Collegium Pharmaceutical share count unchanged in Q1 2026.
  • Collegium Pharmaceutical made up ﹤0.01% of WealthCollab's portfolio in Q1 2026, its #798 holding.
  • WealthCollab first reported a position in Collegium Pharmaceutical in Q2 2024 and has held it in 8 quarters since.
  • WealthCollab's Collegium Pharmaceutical position peaked at $15.2K in Q4 2024.
  • 266 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.

Based on WealthCollab's 13F filing for Q1 2026, filed 13 May 2026.